158 related articles for article (PubMed ID: 21508338)
1. Role of vessel wall and bone marrow syndecan-4 in neointimal hyperplasia: the plot thickens.
Caplice NM
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):952-3. PubMed ID: 21508338
[No Abstract] [Full Text] [Related]
2. Syndecan-4 deficiency limits neointimal formation after vascular injury by regulating vascular smooth muscle cell proliferation and vascular progenitor cell mobilization.
Ikesue M; Matsui Y; Ohta D; Danzaki K; Ito K; Kanayama M; Kurotaki D; Morimoto J; Kojima T; Tsutsui H; Uede T
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1066-74. PubMed ID: 21330609
[TBL] [Abstract][Full Text] [Related]
3. Temporal and spatial characterization of cellular constituents during neointimal hyperplasia after vascular injury: Potential contribution of bone-marrow-derived progenitors to arterial remodeling.
Shoji M; Sata M; Fukuda D; Tanaka K; Sato T; Iso Y; Shibata M; Suzuki H; Koba S; Geshi E; Katagiri T
Cardiovasc Pathol; 2004; 13(6):306-12. PubMed ID: 15556776
[TBL] [Abstract][Full Text] [Related]
4. Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor.
Wang SH; Lin SJ; Chen YH; Lin FY; Shih JC; Wu CC; Wu HL; Chen YL
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):816-22. PubMed ID: 19342598
[TBL] [Abstract][Full Text] [Related]
5. The origin of intimal smooth muscle cells: are we on a steady road back to the past?
De Geest B
Cardiovasc Res; 2009 Jan; 81(1):7-8. PubMed ID: 19004811
[No Abstract] [Full Text] [Related]
6. Redox-sensitive transcription factor Nrf2 regulates vascular smooth muscle cell migration and neointimal hyperplasia.
Ashino T; Yamamoto M; Yoshida T; Numazawa S
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):760-8. PubMed ID: 23413426
[TBL] [Abstract][Full Text] [Related]
7. Leptin Induces Sca-1
Xie Y; Potter CMF; Le Bras A; Nowak WN; Gu W; Bhaloo SI; Zhang Z; Hu Y; Zhang L; Xu Q
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2114-2127. PubMed ID: 28935755
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury.
Murayama H; Takahashi M; Takamoto M; Shiba Y; Ise H; Koyama J; Tagawa Y; Iwakura Y; Ikeda U
Cardiovasc Res; 2008 Nov; 80(2):175-80. PubMed ID: 18791204
[TBL] [Abstract][Full Text] [Related]
9. Urokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cells.
Vallabhaneni KC; Tkachuk S; Kiyan Y; Shushakova N; Haller H; Dumler I; Eden G
Cardiovasc Res; 2011 Apr; 90(1):113-21. PubMed ID: 21088115
[TBL] [Abstract][Full Text] [Related]
10. Does the effect of microRNAs in vascular neointimal formation depend on cell cycle phase?
Silvestri P; Rigattieri S; Loschiavo P
Circ Res; 2008 May; 102(9):e101; author reply e102. PubMed ID: 18467632
[No Abstract] [Full Text] [Related]
11. Hic-5, an adaptor protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo.
Kim-Kaneyama JR; Wachi N; Sata M; Enomoto S; Fukabori K; Koh K; Shibanuma M; Nose K
Biochem Biophys Res Commun; 2008 Nov; 376(4):682-7. PubMed ID: 18812162
[TBL] [Abstract][Full Text] [Related]
12. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
[TBL] [Abstract][Full Text] [Related]
13. The origin of post-injury neointimal cells in the rat balloon injury model.
Rodriguez-Menocal L; St-Pierre M; Wei Y; Khan S; Mateu D; Calfa M; Rahnemai-Azar AA; Striker G; Pham SM; Vazquez-Padron RI
Cardiovasc Res; 2009 Jan; 81(1):46-53. PubMed ID: 18818213
[TBL] [Abstract][Full Text] [Related]
14. Human C-reactive protein enhances thrombus formation after neointimal balloon injury in transgenic rabbits.
Matsuda S; Yamashita A; Sato Y; Kitajima S; Koike T; Sugita C; Moriguchi-Goto S; Hatakeyama K; Takahashi M; Koshimoto C; Matsuura Y; Iwakiri T; Chen YE; Fan J; Asada Y
J Thromb Haemost; 2011 Jan; 9(1):201-8. PubMed ID: 21029360
[TBL] [Abstract][Full Text] [Related]
15. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.
Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
[TBL] [Abstract][Full Text] [Related]
17. Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injury.
Daniel JM; Reich F; Dutzmann J; Weisheit S; Teske R; Gündüz D; Bauersachs J; Preissner KT; Sedding DG
Thromb Haemost; 2015 Aug; 114(3):603-13. PubMed ID: 26063414
[TBL] [Abstract][Full Text] [Related]
18. Vascular cell kinetics in response to intimal injury ex vivo.
Tigerstedt NM; Savolainen-Peltonen H; Lehti S; Hayry P
J Vasc Res; 2010; 47(1):35-44. PubMed ID: 19672106
[TBL] [Abstract][Full Text] [Related]
19. STAT4 deficiency protects against neointima formation following arterial injury in mice.
Lv L; Meng Q; Ye M; Wang P; Xue G
J Mol Cell Cardiol; 2014 Sep; 74():284-94. PubMed ID: 24933129
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.
Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
